vs
INDEPENDENT BANK CORP(INDB)与REPLIGEN CORP(RGEN)财务数据对比。点击上方公司名可切换其他公司
INDEPENDENT BANK CORP的季度营收约是REPLIGEN CORP的1.1倍($212.5M vs $197.9M),INDEPENDENT BANK CORP净利率更高(35.5% vs 6.7%,领先28.7%),INDEPENDENT BANK CORP同比增速更快(46.9% vs 13.6%),INDEPENDENT BANK CORP自由现金流更多($75.5M vs $17.6M),过去两年INDEPENDENT BANK CORP的营收复合增速更高(24.3% vs 14.4%)
Independent Bank Corp是一家总部位于美国密歇根州大急流城的商业银行,业务全部布局于密歇根州内,目前在全州范围内共设有62家实体营业网点,为当地个人及企业客户提供各类银行金融服务。
Repligen是一家全球生命科学企业,专注于创新生物工艺技术与系统的研发及商业化,助力提升生物药生产效率。公司1981年成立,总部位于美国马萨诸塞州沃尔瑟姆,于纳斯达克挂牌上市,股票代码RGEN,截至2025年全球员工超1900人,主要服务生物制药领域客户。
INDB vs RGEN — 直观对比
营收规模更大
INDB
是对方的1.1倍
$197.9M
营收增速更快
INDB
高出33.2%
13.6%
净利率更高
INDB
高出28.7%
6.7%
自由现金流更多
INDB
多$58.0M
$17.6M
两年增速更快
INDB
近两年复合增速
14.4%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $212.5M | $197.9M |
| 净利润 | $75.3M | $13.3M |
| 毛利率 | — | 52.5% |
| 营业利润率 | — | 9.0% |
| 净利率 | 35.5% | 6.7% |
| 营收同比 | 46.9% | 13.6% |
| 净利润同比 | 50.6% | 143.9% |
| 每股收益(稀释后) | $1.51 | $0.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
INDB
RGEN
| Q4 25 | $212.5M | $197.9M | ||
| Q3 25 | $203.3M | $188.8M | ||
| Q2 25 | $147.5M | $182.4M | ||
| Q1 25 | $145.5M | $169.2M | ||
| Q4 24 | $144.7M | $174.1M | ||
| Q3 24 | $141.7M | $154.9M | ||
| Q2 24 | $137.9M | $154.1M | ||
| Q1 24 | $137.4M | $151.3M |
净利润
INDB
RGEN
| Q4 25 | $75.3M | $13.3M | ||
| Q3 25 | $34.3M | $14.9M | ||
| Q2 25 | $51.1M | $14.9M | ||
| Q1 25 | $44.4M | $5.8M | ||
| Q4 24 | $50.0M | $-30.3M | ||
| Q3 24 | $42.9M | $-654.0K | ||
| Q2 24 | $51.3M | $3.3M | ||
| Q1 24 | $47.8M | $2.1M |
毛利率
INDB
RGEN
| Q4 25 | — | 52.5% | ||
| Q3 25 | — | 53.2% | ||
| Q2 25 | — | 50.0% | ||
| Q1 25 | — | 53.6% | ||
| Q4 24 | — | 26.1% | ||
| Q3 24 | — | 50.0% | ||
| Q2 24 | — | 49.8% | ||
| Q1 24 | — | 49.5% |
营业利润率
INDB
RGEN
| Q4 25 | — | 9.0% | ||
| Q3 25 | 21.8% | 8.9% | ||
| Q2 25 | 44.6% | 7.6% | ||
| Q1 25 | 39.3% | 3.9% | ||
| Q4 24 | — | -17.7% | ||
| Q3 24 | 39.0% | -5.1% | ||
| Q2 24 | 48.1% | 1.0% | ||
| Q1 24 | 45.5% | 1.3% |
净利率
INDB
RGEN
| Q4 25 | 35.5% | 6.7% | ||
| Q3 25 | 16.8% | 7.9% | ||
| Q2 25 | 34.6% | 8.2% | ||
| Q1 25 | 30.5% | 3.4% | ||
| Q4 24 | 34.6% | -17.4% | ||
| Q3 24 | 30.3% | -0.4% | ||
| Q2 24 | 37.2% | 2.2% | ||
| Q1 24 | 34.8% | 1.4% |
每股收益(稀释后)
INDB
RGEN
| Q4 25 | $1.51 | $0.24 | ||
| Q3 25 | $0.69 | $0.26 | ||
| Q2 25 | $1.20 | $0.26 | ||
| Q1 25 | $1.04 | $0.10 | ||
| Q4 24 | $1.18 | $-0.55 | ||
| Q3 24 | $1.01 | $-0.01 | ||
| Q2 24 | $1.21 | $0.06 | ||
| Q1 24 | $1.12 | $0.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | — | $767.6M |
| 总债务越低越好 | — | $542.2M |
| 股东权益账面价值 | $3.6B | $2.1B |
| 总资产 | $24.9B | $2.9B |
| 负债/权益比越低杠杆越低 | — | 0.26× |
8季度趋势,按日历期对齐
现金及短期投资
INDB
RGEN
| Q4 25 | — | $767.6M | ||
| Q3 25 | — | $748.7M | ||
| Q2 25 | — | $708.9M | ||
| Q1 25 | — | $697.2M | ||
| Q4 24 | — | $757.4M | ||
| Q3 24 | — | $784.0M | ||
| Q2 24 | — | $809.1M | ||
| Q1 24 | — | $780.6M |
总债务
INDB
RGEN
| Q4 25 | — | $542.2M | ||
| Q3 25 | — | $537.9M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $525.6M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益
INDB
RGEN
| Q4 25 | $3.6B | $2.1B | ||
| Q3 25 | $3.5B | $2.1B | ||
| Q2 25 | $3.1B | $2.1B | ||
| Q1 25 | $3.0B | $2.0B | ||
| Q4 24 | $3.0B | $2.0B | ||
| Q3 24 | $3.0B | $2.0B | ||
| Q2 24 | $2.9B | $2.0B | ||
| Q1 24 | $2.9B | $2.0B |
总资产
INDB
RGEN
| Q4 25 | $24.9B | $2.9B | ||
| Q3 25 | $25.0B | $2.9B | ||
| Q2 25 | $20.0B | $2.9B | ||
| Q1 25 | $19.9B | $2.9B | ||
| Q4 24 | $19.4B | $2.8B | ||
| Q3 24 | $19.4B | $2.8B | ||
| Q2 24 | $19.4B | $2.9B | ||
| Q1 24 | $19.3B | $2.8B |
负债/权益比
INDB
RGEN
| Q4 25 | — | 0.26× | ||
| Q3 25 | — | 0.26× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.27× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $78.9M | $25.7M |
| 自由现金流经营现金流 - 资本支出 | $75.5M | $17.6M |
| 自由现金流率自由现金流/营收 | 35.5% | 8.9% |
| 资本支出强度资本支出/营收 | 1.6% | 4.1% |
| 现金转化率经营现金流/净利润 | 1.05× | 1.93× |
| 过去12个月自由现金流最近4个季度 | $239.0M | $93.9M |
8季度趋势,按日历期对齐
经营现金流
INDB
RGEN
| Q4 25 | $78.9M | $25.7M | ||
| Q3 25 | $52.2M | $48.1M | ||
| Q2 25 | $106.7M | $28.6M | ||
| Q1 25 | $13.3M | $15.0M | ||
| Q4 24 | $42.9M | $39.2M | ||
| Q3 24 | $70.2M | $49.3M | ||
| Q2 24 | $65.6M | $42.2M | ||
| Q1 24 | $51.1M | $44.7M |
自由现金流
INDB
RGEN
| Q4 25 | $75.5M | $17.6M | ||
| Q3 25 | $49.7M | $43.4M | ||
| Q2 25 | $102.5M | $21.5M | ||
| Q1 25 | $11.3M | $11.4M | ||
| Q4 24 | $36.5M | $33.6M | ||
| Q3 24 | $64.4M | $42.3M | ||
| Q2 24 | $61.9M | $37.4M | ||
| Q1 24 | $46.7M | $36.4M |
自由现金流率
INDB
RGEN
| Q4 25 | 35.5% | 8.9% | ||
| Q3 25 | 24.4% | 23.0% | ||
| Q2 25 | 69.5% | 11.8% | ||
| Q1 25 | 7.8% | 6.8% | ||
| Q4 24 | 25.2% | 19.3% | ||
| Q3 24 | 45.4% | 27.3% | ||
| Q2 24 | 44.9% | 24.3% | ||
| Q1 24 | 34.0% | 24.0% |
资本支出强度
INDB
RGEN
| Q4 25 | 1.6% | 4.1% | ||
| Q3 25 | 1.2% | 2.5% | ||
| Q2 25 | 2.9% | 3.9% | ||
| Q1 25 | 1.4% | 2.1% | ||
| Q4 24 | 4.4% | 3.2% | ||
| Q3 24 | 4.1% | 4.5% | ||
| Q2 24 | 2.7% | 3.1% | ||
| Q1 24 | 3.2% | 5.5% |
现金转化率
INDB
RGEN
| Q4 25 | 1.05× | 1.93× | ||
| Q3 25 | 1.52× | 3.23× | ||
| Q2 25 | 2.09× | 1.92× | ||
| Q1 25 | 0.30× | 2.57× | ||
| Q4 24 | 0.86× | — | ||
| Q3 24 | 1.64× | — | ||
| Q2 24 | 1.28× | 12.70× | ||
| Q1 24 | 1.07× | 21.35× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图